Arama Sonuçları - Morschhauser, Franck

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma Yazar: Gribben, John G., Fowler, Nathan, Morschhauser, Franck

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma Yazar: Cartron, Guillaume, Hourcade-Potelleret, Florence, Morschhauser, Franck, Salles, Gilles, Wenger, Michael, Truppel-Hartmann, Anna, Carlile, David J.

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

(18)F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome Yazar: Cottereau, Anne-Ségolène, Nioche, Christophe, Dirand, Anne-Sophie, Clerc, Jérôme, Morschhauser, Franck, Casasnovas, Olivier, Meignan, Michel, Buvat, Irène

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton’s tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059) Yazar: Rule, Simon A., Cartron, Guillaume, Fegan, Christopher, Morschhauser, Franck, Han, Lingling, Mitra, Siddhartha, Salles, Gilles, Dyer, Martin J. S.

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Detection of Non-Hodgkin’s Lymphoma in ovarian cortex pieces during the process of cryopreservation Yazar: Gronier, Héloïse, Terriou, Louis, Robin, Geoffroy, Wacrenier, Agnès, Leroy-Martin, Brigitte, Lefebvre, Catherine, Vinatier, Denis, Morschhauser, Franck, Decanter, Christine

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment Yazar: Vo, Dang-Nghiem, Alexia, Catherine, Allende-Vega, Nerea, Morschhauser, Franck, Houot, Roch, Menard, Cedric, Tarte, Karin, Cartron, Guillaume, Villalba, Martin

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Controversies in the Treatment of Peripheral T-cell Lymphoma Yazar: Bachy, Emmanuel, Broccoli, Alessandro, Dearden, Claire, de Leval, Laurence, Gaulard, Philippe, Koch, Raphael, Morschhauser, Franck, Trümper, Lorenz, Zinzani, Pier Luigi

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma Yazar: Morschhauser, Franck, Salles, Gilles, Le Gouill, Steven, Tilly, Herve, Thieblemont, Catherine, Bouabdallah, Krimo, Fabiani, Bettina, Ménard, Cédric, Tarte, Karin, Cartron, Guillaume, Houot, Roch

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study gr... Yazar: Sibon, David, Morschhauser, Franck, Resche-Rigon, Matthieu, Ghez, David, Dupuis, Jehan, Marçais, Ambroise, Deau-Fischer, Bénédicte, Bouabdallah, Reda, Sebban, Catherine, Salles, Gilles, Brice, Pauline

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial Yazar: Morschhauser, Franck, Ghosh, Nilanjan, Lossos, Izidore S., Palomba, M. Lia, Mehta, Amitkumar, Casasnovas, Olivier, Stevens, Don, Katakam, Sudhakar, Knapp, Andrea, Nielsen, Tina, McCord, Ron, Salles, Gilles

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30(+) Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient... Yazar: Perrot, Aurore, Monjanel, Hélène, Bouabdallah, Réda, Quittet, Philippe, Sarkozy, Clémentine, Bernard, Marc, Stamatoullas, Aspasia, Borel, Cécile, Bouabdallah, Krimo, Nicolas-Virelizier, Emmanuelle, Fournier, Marion, Morschhauser, Franck, Brice, Pauline

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Lenalidomide triggers T-cell effector functions in vivo in patients with follicular lymphoma Yazar: Ménard, Cédric, Rossille, Delphine, Dulong, Joelle, Nguyen, Tien-Tuan, Papa, Ilenia, Latour, Maelle, Bescher, Nadège, Bezier, Isabelle, Chouteau, Myriam, Fest, Thierry, Houot, Roch, Morschhauser, Franck, Tarte, Karin

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial Yazar: Montillo, Marco, Illés, Árpád, Robak, Tadeusz, Pristupa, Alexander S., Wach, Malgorzata, Egyed, Miklós, Delgado, Julio, Jurczak, Wojciech, Morschhauser, Franck, Schuh, Anna, Eradat, Herbert, Shreay, Sanatan, Barrientos, Jacqueline C., Zelenetz, Andrew D.

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid Lymphomas Yazar: Revailler, Wendy, Cottereau, Anne Ségolène, Rossi, Cedric, Noyelle, Rudy, Trouillard, Thomas, Morschhauser, Franck, Casasnovas, Olivier, Thieblemont, Catherine, Le Gouill, Steven, André, Marc, Ghesquieres, Herve, Ricci, Romain, Meignan, Michel, Kanoun, Salim

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study Yazar: Ribrag, Vincent, Kim, Won Seog, Bouabdallah, Reda, Lim, Soon Thye, Coiffier, Bertrand, Illes, Arpad, Lemieux, Bernard, Dyer, Martin J. S., Offner, Fritz, Felloussi, Zakia, Kloos, Ioana, Luan, Ying, Vezan, Remus, Graef, Thorsten, Morschhauser, Franck

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

The landscape of new drugs in lymphoma Yazar: Younes, Anas, Ansell, Stephen, Fowler, Nathan, Wilson, Wyndham, de Vos, Sven, Seymour, John, Advani, Ranjana, Forero, Andres, Morschhauser, Franck, Kersten, Marie Jose, Tobinai, Kensei, Zinzani, Pier Luigi, Zucca, Emanuele, Abramson, Jeremy, Vose, Julie

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group Yazar: Bonnet, Christophe, Dupuis, Jehan, Tilly, Hervé, Lamy, Thierry, Fruchart, Christophe, le Gouill, Steven, Thieblemont, Catherine, Morschhauser, Franck, Casasnovas, Olivier, Bouabdallah, Krimo, Ghesquieres, Hervé, Van Den Neste, Eric, André, Marc, Cartron, Guillaume, Salles, Gilles

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma Yazar: Pro, Barbara, Horwitz, Steven M., Prince, H. Miles, Foss, Francine M., Sokol, Lubomir, Greenwood, Matthew, Caballero, Dolores, Morschhauser, Franck, Wilhelm, Martin, Iyer, Swaminathan Padmanabhan, Shustov, Andrei R., Wolfson, Julie, Balser, Barbara E., Coiffier, Bertrand

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA Yazar: Delfau-Larue, Marie-Hélène, de Leval, Laurence, Joly, Bertrand, Plonquet, Anne, Challine, Dominique, Parrens, Marie, Delmer, Alain, Salles, Gilles, Morschhauser, Franck, Delarue, Richard, Brice, Pauline, Bouabdallah, Reda, Casasnovas, Olivier, Tilly, Hervé, Gaulard, Philippe, Haioun, Corinne

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma Yazar: Chiu, Hsiling, Trisal, Preeti, Bjorklund, Chad, Carrancio, Soraya, Toraño, Estela G., Guarinos, Carla, Papazoglou, Despoina, Hagner, Patrick R., Beldi‐Ferchiou, Asma, Tarte, Karin, Delfau‐Larue, Marie‐Hélène, Morschhauser, Franck, Ramsay, Alan G., Gandhi, Anita K.

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim